key: cord-0856577-ae3lvv0i
authors: Tan, Chuen Wen; Low, Jenny Guek Hong; Wong, Wan Hui; Chua, Ying Ying; Goh, Sher Li; Ng, Heng Joo
title: Critically ill COVID‐19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability
date: 2020-05-04
journal: Am J Hematol
DOI: 10.1002/ajh.25822
sha: 0146fd029776f584bc2927d52994c25c79a85944
doc_id: 856577
cord_uid: ae3lvv0i

nan

events, 1 and the pathophysiology of this association is multifactorial. 2 Although most ARIs are mild, subpopulation of patients can progress to severe disease with excessive proinflammatory response, and downstream uncontrolled cytokine storm being partially implicated for this severe manifestation. 3 infection given our previous finding that min1, in comparison to min2 and max2, is more strongly associated with thrombotic events. 5 Consistent with published reports, 4 all the patients expressed high CRP levels even on initial assessment during hospitalization, while procalcitonin remained unremarkable (data not shown). We did not observe a definitive pattern of association between CRP and ICU admission -patient 3 had a CRP upon ICU admission that was lower than that of patient 1 upon initial hospitalization. In contrast, as these patients' clinical conditions turned critical, min1 seemed to be the first CWA parameter to rise, with all three patients exhibiting raised min1 upon ICU admission. This raises the exciting possibility that high min1 may be a useful biomarker to predict severity in COVID-19 infected patients, but further study is needed.

From the second day of ICU admission onward, all the CWA parameters became markedly elevated for at least the ensuing 4 days of ICU stay. Many of the levels were at least as high as what we noted in acute venous thromboembolism, which had an odds ratio of four or greater for thrombotic events. 5 Of note, although none of our cases T A B L E 1

Laboratory results and clinical features of COVID-19 infected patients in reference to the normal intervals of clot waveform analysis (CWA) parameters and CWA data of patients with bacterial and other viral acute respiratory tract infections.

Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting

Acute respiratory tract infection leads to procoagulant changes in human subjects

The cytokine storm of severe influenza and development of immunomodulatory therapy

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism

Cross Talk Pathways between Coagulation and Inflammation

Joo Ng H. APTT-based clot waveform analysis in various infections